Clinical trial Recruiting at 1 site Interventional Ages 18 to 75 Women only

Comparing dexmedetomidine and lidocaine for pain management after mastectomy

Official title: Dexmedetomidine Versus Lidocaine Infusions as Adjuvants to General Anesthesia for Chronic Pain Management After Mastectomy: A Randomized Controlled Trial

Run by Cairo University · NCT06910644 · Data updated 2026-11-12

This study is testing whether dexmedetomidine or lidocaine works better for managing pain after mastectomy surgery in adults aged 18 to 75.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexWomen only
Enrollment90 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedApril 5, 2025
Main results expectedDecember 1, 2025
Study endsDecember 1, 2025
Registry record updatedApril 8, 2025
Trial IDNCT06910644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 75 scheduled for mastectomy with axillary dissection due to breast cancer.

Probably not a fit

Patients with known allergies to the study drugs, hepatic or renal insufficiency, or those on certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of dexmedetomidine and lidocaine infusions as adjuvants to general anesthesia in managing chronic pain following mastectomy. Chronic pain is a significant issue for patients undergoing breast cancer surgery, and this research aims to determine which infusion provides better pain relief. The study involves patients aged 18 to 75 who are scheduled for mastectomy with axillary dissection and evaluates the outcomes of both medications in a controlled setting.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies for patients recovering from mastectomy.

How similar studies have gone: While there have been studies on the use of adjuvants in anesthesia, the specific comparison of dexmedetomidine and lidocaine in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age from 18 to 75 years.
* American Society of Anesthesiologists (ASA) physical status II.
* Scheduled for mastectomy with axillary dissection (either modified radical mastectomy with or without latissimus dorsi flap or conservative breast surgery) due to breast cancer.

Exclusion Criteria:

* Patient refusal.
* Known allergy to any of the study drugs.
* Those with hepatic or renal insufficiency.
* Patients who are running regularly on B blockers.
* α2 adrenergic agonists and sedatives.
* Psychoactive medications.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.